Debt-to-equity of NORTHWEST BIOTHERAPEUTICS INC from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NORTHWEST BIOTHERAPEUTICS INC quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • NORTHWEST BIOTHERAPEUTICS INC Debt-to-equity for the quarter ending 30 Sep 2025 was -114%, a 0.32% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NORTHWEST BIOTHERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -114% -0.36% -0.32% 30 Sep 2025
Q2 2025 -114% -5% -4.6% 30 Jun 2025
Q1 2025 -113% -6.1% -5.6% 31 Mar 2025
Q4 2024 -113% -5.2% -4.8% 31 Dec 2024
Q3 2024 -114% -7.7% -7.2% 30 Sep 2024
Q2 2024 -109% +1.5% +1.3% 30 Jun 2024
Q1 2024 -107% +8.8% +7.6% 31 Mar 2024
Q4 2023 -108% +11% +9% 31 Dec 2023
Q3 2023 -106% +20% +16% 30 Sep 2023
Q2 2023 -111% +9.2% +7.6% 30 Jun 2023
Q1 2023 -116% -1.9% -1.7% 31 Mar 2023
Q4 2022 -119% -7.2% -6.4% 31 Dec 2022
Q3 2022 -126% -17% -16% 30 Sep 2022
Q2 2022 -120% -10% -9.5% 30 Jun 2022
Q1 2022 -114% -3.8% -3.4% 31 Mar 2022
Q4 2021 -111% +0.16% +0.14% 31 Dec 2021
Q3 2021 -109% +6.6% +5.7% 30 Sep 2021
Q2 2021 -109% +8.8% +7.4% 30 Jun 2021
Q1 2021 -110% +11% +8.8% 31 Mar 2021
Q4 2020 -112% +15% +12% 31 Dec 2020
Q3 2020 -116% +17% +13% 30 Sep 2020
Q2 2020 -118% +34% +22% 30 Jun 2020
Q1 2020 -121% +30% +20% 31 Mar 2020
Q4 2019 -127% +23% +15% 31 Dec 2019
Q3 2019 -132% +16% +11% 30 Sep 2019
Q2 2019 -152% -1.6% -1% 30 Jun 2019
Q1 2019 -151% +18% +11% 31 Mar 2019
Q4 2018 -150% +46% +23% 31 Dec 2018
Q3 2018 -148% +92% +38% 30 Sep 2018
Q2 2018 -150% +141% +48% 30 Jun 2018
Q1 2018 -170% +162% +49% 31 Mar 2018
Q4 2017 -196% +285% +59% 31 Dec 2017
Q3 2017 -240% +530% +69% 30 Sep 2017
Q2 2017 -291% +80% +22% 30 Jun 2017
Q1 2017 -332% -59% -22% 31 Mar 2017
Q4 2016 -480% -267% -126% 31 Dec 2016
Q3 2016 -770% -577% -300% 30 Sep 2016
Q2 2016 -371% -177% -92% 30 Jun 2016
Q1 2016 -272% 31 Mar 2016
Q4 2015 -213% 31 Dec 2015
Q3 2015 -193% 30 Sep 2015
Q2 2015 -194% 30 Jun 2015
Q4 2013 -86% +12% +12% 31 Dec 2013
Q3 2013 -73% +28% +28% 30 Sep 2013
Q2 2013 -80% +22% +22% 30 Jun 2013
Q1 2013 -89% +17% +16% 31 Mar 2013
Q4 2012 -98% 31 Dec 2012
Q3 2012 -101% 30 Sep 2012
Q2 2012 -102% 30 Jun 2012
Q1 2012 -105% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.